Literature DB >> 10898697

Selection of naturally occurring extended-spectrum TEM beta-lactamase variants by fluctuating beta-lactam pressure.

J Blazquez1, M I Morosini, M C Negri, F Baquero.   

Abstract

Despite the large number of in vitro mutations that increase resistance to extended-spectrum cephalosporins in TEM-type beta-lactamases, only a small number occur in naturally occurring enzymes. In nature, and particularly in the hospital, bacteria that contain beta-lactamases encounter simultaneous or consecutive selective pressure with different beta-lactam molecules. All variants obtained by submitting an Escherichia coli strain that contains a bla(TEM-1) gene to fluctuating challenge with both ceftazidime and amoxicillin contained only mutations previously detected in naturally occurring beta-lactamases. Nevertheless, some variants obtained by ceftazidime challenge alone contained mutations never detected in naturally occurring TEM beta-lactamases, suggesting that extended-spectrum TEM variants in hospital isolates result from fluctuating selective pressure with several beta-lactams rather than selection with a single antibiotic.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898697      PMCID: PMC90035          DOI: 10.1128/AAC.44.8.2182-2184.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamase.

Authors:  S Farzaneh; E B Chaibi; J Peduzzi; M Barthelemy; R Labia; J Blazquez; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

2.  A natural polymorphism in beta-lactamase is a global suppressor.

Authors:  W Huang; T Palzkill
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

Review 3.  Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics.

Authors:  A A Medeiros
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

4.  An additional ionic bond suggested by molecular modelling of TEM-2 might induce a slight discrepancy between catalytic properties of TEM-1 and TEM-2 beta-lactamases.

Authors:  E B Chaïbi; S Farzaneh; J Péduzzi; M Barthélémy; R Labia
Journal:  FEMS Microbiol Lett       Date:  1996-10-01       Impact factor: 2.742

Review 5.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

6.  Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.

Authors:  J Blazquez; M R Baquero; R Canton; I Alos; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

7.  Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.

Authors:  J F Petrosino; T Palzkill
Journal:  J Bacteriol       Date:  1996-04       Impact factor: 3.490

8.  Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of beta-lactamase.

Authors:  T Palzkill; Q Q Le; K V Venkatachalam; M LaRocco; H Ocera
Journal:  Mol Microbiol       Date:  1994-04       Impact factor: 3.501

9.  Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases.

Authors:  J Blazquez; M I Morosini; M C Negri; M Gonzalez-Leiza; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

10.  Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime.

Authors:  C Cantu; W Huang; T Palzkill
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

View more
  16 in total

1.  Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the tem beta-lactamase.

Authors:  Miriam Barlow; Barry G Hall
Journal:  Genetics       Date:  2002-03       Impact factor: 4.562

Review 2.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance.

Authors:  M C Negri; M Lipsitch; J Blázquez; B R Levin; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

4.  Experimental prediction of the natural evolution of antibiotic resistance.

Authors:  Miriam Barlow; Barry G Hall
Journal:  Genetics       Date:  2003-04       Impact factor: 4.562

5.  Predicting evolution by in vitro evolution requires determining evolutionary pathways.

Authors:  Barry G Hall
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

6.  bla(SHV) Genes in Klebsiella pneumoniae: different allele distributions are associated with different promoters within individual isolates.

Authors:  David S Hammond; Jacqueline M Schooneveldt; Graeme R Nimmo; Flavia Huygens; Philip M Giffard
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 7.  Genetic constraints on protein evolution.

Authors:  Manel Camps; Asael Herman; Ern Loh; Lawrence A Loeb
Journal:  Crit Rev Biochem Mol Biol       Date:  2007 Sep-Oct       Impact factor: 8.250

Review 8.  Origin and proliferation of multiple-drug resistance in bacterial pathogens.

Authors:  Hsiao-Han Chang; Ted Cohen; Yonatan H Grad; William P Hanage; Thomas F O'Brien; Marc Lipsitch
Journal:  Microbiol Mol Biol Rev       Date:  2015-03       Impact factor: 11.056

9.  Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance.

Authors:  Angela Novais; Iñaki Comas; Fernando Baquero; Rafael Cantón; Teresa M Coque; Andrés Moya; Fernando González-Candelas; Juan-Carlos Galán
Journal:  PLoS Pathog       Date:  2010-01-22       Impact factor: 6.823

10.  Extended Spectrum beta-Lactamases among Gram-Negative Bacterial Isolates from Clinical Specimens in Three Major Hospitals in Northern Jordan.

Authors:  Raymond G Batchoun; Samer F Swedan; Abdullah M Shurman
Journal:  Int J Microbiol       Date:  2009-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.